Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Hydrogel Urothelial Cancer Therapies
10
Mins
June 2025
Urological cancers are malignancies that affect the organs of the urinary system and male reproductive system. Of these, bladder cancer…
Read more
9
Mins
17 Sep 2020
Metastasis: A Bane of Breast Cancer Therapy
Breast cancer is one of the most commonly diagnosed cancers among women.1 Despite advances in treatment for breast cancer…
12
Mins
17 Sep 2020
Putting into Perspective the Future of Cancer Vaccines: Targeted Immunotherapy
Cancer is a genetic and epigenetic disease of multicellularity, driving transformed cells to uncontrolled growth, invasion, and metastasis. In cancer, intracellular mechanisms controlling cellular proliferation are damaged first, which allows certain cells to progress to malignant transformation…
14
Mins
10 Sep 2020
Unmet Medical Need in Patients with Metastatic Colorectal Cancer with BRAF V600E Mutations: A Review
Colorectal cancer (CRC) is the most common gastrointestinal malignancy. Worldwide, it is the second most common cancer in females…
8
Mins
26 Aug 2020
Review of the Latest Developments in Treatment of Hormone Receptor-Positive Advanced Breast Cancer
MONARCH 2 was a global, randomised, double-blind, Phase III study of abemaciclib or placebo in combination with fulvestrant in premenopausal…
14
Mins
26 Aug 2020
Latest Developments in Advanced Breast Cancer Treatment: A Discussion with Two Key Opinion Leaders about the CDK4/6 Inhibitors Abemaciclib, Palbociclib, and Ribociclib
The introduction of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in the treatment of advanced breast cancer (ABC; inoperable locally advanced…
10
Mins
24 Aug 2020
Adaptations and Advancement of Biologic Immunotherapy in the Management of Immunologically Cold Solid Malignancies
Contemporary breakthroughs within cancer immunotherapy are frequently cited amongst the most promising of therapeutic directions for medical oncology…
10
Mins
4 Aug 2020
Initiatives to Improve Control, Resource Use, and Quality of Life Associated with Chemotherapy-Induced Nausea and Vomiting
This review set out to identify the initiatives needed to achieve better cancer-induced nausea and vomiting (CINV) control worldwide…
9
Mins
23 Jun 2020
Breast Cancer Immunotherapy: From Biology to Current Clinical Applications
The complexity behind the treatment of breast cancer arises, in part, from the presence of biologically distinct subtypes…
Loading posts...
« Previous
1
…
12
13
14
15
16
…
29
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View